Drugs /
copper gluconate
Overview
Clinical Trials
Copper gluconate has been investigated in 3 clinical trials, of which 1 is open and 2 are closed. Of the trials investigating copper gluconate, 1 is phase 1 (1 open) and 2 are phase 2 (0 open).
Glioblastoma, multiple myeloma, and pancreatic adenocarcinoma are the most common diseases being investigated in copper gluconate clinical trials [2].
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.